Anne E. O’Donnell

4.0k total citations · 2 hit papers
51 papers, 2.0k citations indexed

About

Anne E. O’Donnell is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Anne E. O’Donnell has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 13 papers in Epidemiology and 7 papers in Emergency Medical Services. Recurrent topics in Anne E. O’Donnell's work include Cystic Fibrosis Research Advances (31 papers), Tracheal and airway disorders (17 papers) and Neonatal Respiratory Health Research (15 papers). Anne E. O’Donnell is often cited by papers focused on Cystic Fibrosis Research Advances (31 papers), Tracheal and airway disorders (17 papers) and Neonatal Respiratory Health Research (15 papers). Anne E. O’Donnell collaborates with scholars based in United States, United Kingdom and Germany. Anne E. O’Donnell's co-authors include Jonathan Ilowite, Alan F. Barker, Robert B. Fick, Armand Wolff, Mark L. Metersky, James D. Chalmers, Charles L. Daley, Matthias Salathé, Charles Haworth and Alexandra L. Quittner and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Anne E. O’Donnell

47 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adult Patients With Bronchiectasis

2016 251 citations Timothy R. Aksamit, Anne E. O’Donnell et al. CHEST Journal profile →
Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis

2020 207 citations James D. Chalmers, Mark L. Metersky et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne E. O’Donnell United States	19	1.5k	603	213	208	197	51	2.0k
Rosa Girón Spain	25	1.9k 1.2×	496 0.8×	153 0.7×	192 0.9×	140 0.7×	138	2.2k
J. Angrill Spain	16	986 0.6×	534 0.9×	76 0.4×	210 1.0×	80 0.4×	24	1.4k
Melissa J. McDonnell Ireland	20	2.3k 1.5×	557 0.9×	288 1.4×	231 1.1×	84 0.4×	62	2.5k
Casilda Olveira Spain	31	2.5k 1.6×	504 0.8×	280 1.3×	256 1.2×	66 0.3×	94	2.8k
J M Littlewood United Kingdom	26	1.6k 1.0×	400 0.7×	108 0.5×	77 0.4×	129 0.7×	72	2.5k
Casper S. de Graaff Netherlands	15	732 0.5×	546 0.9×	50 0.2×	93 0.4×	71 0.4×	27	1.2k
Christopher M. Oermann United States	22	1.6k 1.0×	460 0.8×	76 0.4×	85 0.4×	110 0.6×	59	2.0k
Anders Lindblad Sweden	25	2.1k 1.3×	559 0.9×	101 0.5×	51 0.2×	255 1.3×	80	2.7k
Elliott C. Dasenbrook United States	20	1.3k 0.8×	361 0.6×	53 0.2×	59 0.3×	412 2.1×	39	1.6k
Chee Y. Ooi Australia	32	1.7k 1.1×	258 0.4×	242 1.1×	146 0.7×	111 0.6×	121	2.9k

Countries citing papers authored by Anne E. O’Donnell

Since Specialization

Citations

This map shows the geographic impact of Anne E. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne E. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne E. O’Donnell more than expected).

Fields of papers citing papers by Anne E. O’Donnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne E. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne E. O’Donnell. The network helps show where Anne E. O’Donnell may publish in the future.

Co-authorship network of co-authors of Anne E. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of Anne E. O’Donnell. A scholar is included among the top collaborators of Anne E. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne E. O’Donnell. Anne E. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chalmers, James D., Michal Shteinberg, Sanjay H. Chotirmall, et al.. (2025). Study Design of a Phase III Study (AIRTIVITY®) of the Novel Cathepsin C (Dipeptidyl Peptidase 1) Inhibitor BI 1291583 in People With Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1964–A1964. 1 indexed citations

O’Donnell, Anne E., et al.. (2025). Prevalence of clinically significant refractive error in children in Europe: Systematic review and meta-analysis. PLoS ONE. 20(11). e0335666–e0335666.

Flume, Patrick A., Ashwin Basavaraj, Bryan Garcia, et al.. (2023). Towards development of evidence to inform recommendations for the evaluation and management of bronchiectasis. Respiratory Medicine. 211. 107217–107217. 8 indexed citations

Chalmers, James D., Abhya Gupta, Sanjay H. Chotirmall, et al.. (2023). A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: Airleaf. ERJ Open Research. 9(3). 633–2022. 22 indexed citations

Griffith, David E., Gina Eagle, Rachel Thomson, et al.. (2018). Randomized Phase 3 Trial of Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC) in Adult Patients. American Journal of Respiratory and Critical Care Medicine. 197. 1 indexed citations

Winthrop, Kevin, Gina Eagle, Rachel Thomson, et al.. (2018). Six-Minute Walk Test (6MWT) Performance in Adult Patients Receiving Amikacin Liposome Inhalation Suspension (ALIS) for Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC). American Journal of Respiratory and Critical Care Medicine. 197.

O’Donnell, Anne E.. (2018). Medical management of bronchiectasis. Journal of Thoracic Disease. 10(S28). S3428–S3435. 10 indexed citations

Henkle, Emily, Timothy R. Aksamit, Charles L. Daley, et al.. (2018). US Patient-Centered Research Priorities and Roadmap for Bronchiectasis. CHEST Journal. 154(5). 1016–1023. 8 indexed citations

O’Donnell, Anne E. & Timothy R. Aksamit. (2018). 3rd World Bronchiectasis Conference. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 5(4). 302–323. 1 indexed citations

10.

Metersky, Mark L., Timothy R. Aksamit, Alan R. Barker, et al.. (2018). The Prevalence and Significance of Staphylococcus aureus in Patients with Non–Cystic Fibrosis Bronchiectasis. Annals of the American Thoracic Society. 15(3). 365–370. 32 indexed citations

11.

Aksamit, Timothy R., Anne E. O’Donnell, Alan R. Barker, et al.. (2016). Adult Patients With Bronchiectasis. CHEST Journal. 151(5). 982–992. 251 indexed citations breakdown →

12.

Barker, Alan F., Anne E. O’Donnell, Patrick A. Flume, et al.. (2014). Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials. The Lancet Respiratory Medicine. 2(9). 738–749. 153 indexed citations

13.

Quittner, Alexandra L., Anne E. O’Donnell, Matthias Salathé, et al.. (2014). Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores. Thorax. 70(1). 12–20. 121 indexed citations

14.

Metersky, Mark L. & Anne E. O’Donnell. (2012). Preface. Clinics in Chest Medicine. 33(2). xi–xii. 2 indexed citations

15.

O’Donnell, Anne E.. (2008). Bronchiectasis. CHEST Journal. 134(4). 815–823. 158 indexed citations

16.

O’Donnell, Anne E.. (1996). HIV IN ILLICIT DRUG USERS. Clinics in Chest Medicine. 17(4). 797–807. 6 indexed citations

17.

O’Donnell, Anne E., et al.. (1995). Pulmonary Complications Associated With Illicit Drug Use. CHEST Journal. 108(2). 460–463. 35 indexed citations

18.

O’Donnell, Anne E.. (1993). Exercise-induced Airflow Obstruction in a Healthy Military Population. CHEST Journal. 103(3). 742–744. 27 indexed citations

19.

O’Donnell, Anne E., et al.. (1988). Pulmonary Complications of Intravenous Drug Abuse. CHEST Journal. 94(2). 251–253. 54 indexed citations

20.

O’Donnell, Anne E., et al.. (1987). Endobronchial Eosinophilic Granuloma: A Rare Cause of Total Lung Atelectasis. American Review of Respiratory Disease. 136(6). 1478–1480. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact